Medicine · 2023
Fatal invasive pulmonary aspergillosis in non-immunocompromised host: A case report.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ao Wanping, Huang Ping, Wang Jinjing, Fu Xiaoyun, Fu Bao
Аннотация
RATIONALE: Invasive pulmonary aspergillosis (IPA) is an uncommon but life-threatening disease. The disease often occurs in immunocompromised patients or critically ill patients. Here, we reported that IPA occurred in a non-immunocompromised host.
PATIENT CONCERNS: A 45-year-old man was admitted to the hospital for 1 week due to fever and cough. He was engaged in waste recycling and lived in a dark and humid environment for a long time.
DIAGNOSIS: Invasive pulmonary aspergillosis.
INTERVENTIONS: Next generation sequencing and pathological examination of alveolar lavage fluid indicated aspergillus infection. He received voriconazole infusion after admission. After 5 weeks of antifungal treatment, his condition improved significantly and discharged.
OUTCOME: One week after discharge, his condition deteriorated again and returned to the hospital. Unfortunately, he died.
LESSON: The immunocompetent adults can develop invasive pulmonary aspergillosis if they are exposed to high-risk environments. IPA in non-immunocompromised host should arouse the vigilance of clinicians.
PATIENT CONCERNS: A 45-year-old man was admitted to the hospital for 1 week due to fever and cough. He was engaged in waste recycling and lived in a dark and humid environment for a long time.
DIAGNOSIS: Invasive pulmonary aspergillosis.
INTERVENTIONS: Next generation sequencing and pathological examination of alveolar lavage fluid indicated aspergillus infection. He received voriconazole infusion after admission. After 5 weeks of antifungal treatment, his condition improved significantly and discharged.
OUTCOME: One week after discharge, his condition deteriorated again and returned to the hospital. Unfortunately, he died.
LESSON: The immunocompetent adults can develop invasive pulmonary aspergillosis if they are exposed to high-risk environments. IPA in non-immunocompromised host should arouse the vigilance of clinicians.